CALYPTE BIOMEDICAL CORP (CBMC)

Recent Material Events for CALYPTE BIOMEDICAL CORP
Date Description
Jan 03, 2013 On December 27, 2012, Calypte Biomedical Corporation (the “Company”) entered into employment agreements with Adel Karas, its President and Chief Executive Officer and a member of its Board of Directors, and Kartlos Edilashvili, its Chief
Nov 15, 2012 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
Nov 15, 2012 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
Apr 30, 2012 (c) On April 24, 2012, Kartlos Edilashvili, a member of the registrant’s Board of Directors, was elected as the Chief Financial Officer and Secretary of the registrant, replacing Adel Karas, who will continue as the registrant’s Chairman
Nov 15, 2011 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
Nov 15, 2011 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
Oct 14, 2011 The Registrant and David Khidasheli have entered into a Memorandum of Understanding dated October 10, 2011 (the “MOU”) pursuant to which Mr. Khidasheli has agreed to invest a total of $1,000,000 in the Registrant. The investment will cons
Aug 16, 2011 If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
May 27, 2011 Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).
May 27, 2011 Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).